D-amphetamine is a competitive inhibitor of DAT, NAT, and VMAT. Lisdexamfetamine is a produg of d-amphetamine which is linked to the amino acid
Competitive inhibitor at DAT competing with dopamine and noradrenaline at NAT. Competitive inhibitor of VMAT. Click to enlarge. Downloadable
Other than stopping or switching antipsychotic medication, the strongest current evidence for TD treatment is the use of the VMAT inhibitors, deutetrabenazine
by K Subramanian 2024adverse effects (AEs) of antipsychotics and other dopamine receptor blockers. VMAT Inhibitors. Three VMAT2 inhibitors have been
Lactation. Tetrabenazine is contraindicated during lactation (see section 4.3). Tetrabenazine works mainly as a VMAT inhibitor and, as such
The most effective treatments for stuttering include second-generation antipsychotics, selective D1 antagonism, VMAT-2 inhibitors
The VMAT-2 inhibitors, the approved and recommended treatments for TD, can cause drug-induced Parkinsonism in some people. And anticholinergics
by S Frank 2024 Cited by 1In regards to drug interactions, CYP2D6 inhibitors (eg VMAT inhibitor reserpine is contraindicated. The reason is that the
Comparison of VMAT-2 Inhibitors for Tardive Dyskinesia ; Contraindications relevant to TD, None, Hepatic impairment, use of reserpine, MAOIs
Comments